LABCORP ADVANCES LEADERSHIP POSITION IN DRUG METABOLISM TESTING

A A

Laboratory Corporation of America Holdings (LabCorp) , a national leader in pharmacogenetic testing, today announced that it has begun offering a personalized drug response interpretation service for cytochrome P450 (CYP450) testing called Signature Genetics to complement its expanding menu of genetic tests for CYP450 mutations.
Finanzen.net